Table 3 OB/GYNs’ knowledge and perceptions of contraceptives clinical application and side effects
Questions | Yes, n (%) | No, n (%) | Don’t Know, n (%) |
|---|---|---|---|
• Gestational trophoblastic patients may take low dose of COC | 210 (20.4) | 500 (48.7) | 317 (30.9) |
• Should consider pregnancy 3–6 months after stopping the intake of COC | 252 (24.5) | 681 (66.3) | 94 (9.2) |
• Taking COC for long term is harmful to health; however, interrupted intake is recommended | 193 (18.8) | 706 (68.7) | 128 (12.5) |
• Taking COC may reduce the fertility of women | 77 (7.5) | 822 (80.0) | 128 (12.5) |
• Taking COC for a long term may cause amenorrhea and premature ovarian failure | 109 (10.6) | 779 (75.9) | 139 (13.5) |
• Taking COC may increase the risk of thrombi formation | 675 (65.7) | 215 (20.9) | 137 (13.3) |
• Taking COC may increase the risk of breast cancer | 381 (37.1) | 466 (45.4) | 180 (17.5) |
• Taking COC may cause weight gain | 511 (49.8) | 376 (36.6) | 140 (13.6) |